1 |
Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases [J]. Eur J Radiol, 2019, 112: 14-21.
|
2 |
Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer [J]. Surg Clin North Am, 1987, 67(2): 251-261.
|
3 |
刘丽, 徐辉雄, 吕明德, 等. 甲状腺癌颈部淋巴结转移的超声特征 [J]. 中华医学超声杂志(电子版), 2007, 4(3): 156-158.
|
4 |
李潜. 甲状腺乳头状癌及其颈部淋巴结转移的超声特征以及BRAF和NRAS突变分析 [D]. 郑州: 郑州大学, 2018.
|
5 |
Yu J, Deng Y, Liu T, et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics [J]. Nat Commun, 2020, 11(1): 4807.
|
6 |
Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee [J]. J Am Coll Radiol, 2017, 14(5): 587-595.
|
7 |
孙辉, 李世杰, 付言涛, 等. 分化型甲状腺癌功能性或传统性颈淋巴结清扫的利弊 [J/CD]. 中华普外科手术学杂志(电子版), 2018, 12(6): 455-457.
|
8 |
中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会. 分化型甲状腺癌颈侧区淋巴结清扫专家共识(2017版) [J]. 中国实用外科杂志, 2017, 37(9): 985-991.
|
9 |
王宇, 沈强, 渠宁. 分化型甲状腺癌颈侧区淋巴结清扫术中神经损伤的预防 [J]. 中国实用外科杂志, 2018, 38(6): 624-628.
|
10 |
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation [J]. Thyroid, 2014, 24(1): 27-34.
|
11 |
Cho SY, Lee TH, Ku YH, et al. Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia [J]. Surgery, 2015, 157(1): 111-118.
|
12 |
中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会. 分化型甲状腺癌颈侧区淋巴结清扫专家共识(2017版) [J]. 中国实用外科杂志, 2017, 37(9): 985-991.
|
13 |
Miyauchi A, Kudo T, Ito Y, et al. Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance [J]. Surgery, 2018, 163(1): 48-52.
|
14 |
Oh HS, Ha J, Kim HI, et al. Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea [J]. Thyroid, 2018, 28(12): 1587-1594.
|
15 |
Tuttle RM, Fagin JA, Minkowitz G, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance [J]. JAMA Otolaryngol Head Neck Surg, 2017, 143(10): 1015-1020.
|
16 |
郭又铭, 霍金龙, 瞿锐, 等. 全腔镜手术与传统手术治疗早期分化型甲状腺癌的疗效对比分析 [J]. 医学食疗与健康, 2019, 17(12): 26, 28.
|
17 |
Ito Y, Higashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection [J]. World J Surg, 2007, 31(11): 2085-2091.
|
18 |
刘威, 王聪, 薛安慰, 等. 单侧cN0甲状腺癌病人中央区淋巴结转移特性及其预防性清扫 [J]. 外科理论与实践, 2021, 26(2): 159-162.
|
19 |
Kim H, Kwon H, Moon BI. Association of multifocality with prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis [J]. JAMA Otolaryngol Head Neck Surg, 2021, 147(10): 847-854.
|
20 |
李想, 黄韬, 刁畅, 等. 甲状腺球蛋白抗体和甲状腺过氧化物酶抗体状态对分化型甲状腺癌患者中央区淋巴结影响的多中心临床研究 [J]. 中国普外基础与临床杂志, 2020, 27(11): 1392-1396.
|
21 |
Kim HI, Jang HW, Ahn HS, et al. High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance [J]. J Clin Endocrinol Metab, 2018, 103(2): 446-451.
|